Rhumbline Advisers Castle Biosciences Inc Transaction History

Rhumbline Advisers

$105 Billion
Q2 2024

A detailed history of Rhumbline Advisers transactions in Castle Biosciences Inc stock. As of the latest transaction made, Rhumbline Advisers holds 41,896 shares of CSTL stock, worth $1.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,896

Previous 38,908 7.68%

Holding current value

$1.4 Million

Previous $861,000 5.92%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	BUY	$18.84 - $24.94 $56,293 - $74,520	2,988 Added 7.68%	41,896 $912,000
Q1 2024 May 09, 2024	BUY	$18.06 - $25.3 $18,060 - $25,300	1,000 Added 2.64%	38,908 $861,000
Q4 2023 Feb 08, 2024	BUY	$12.19 - $22.43 $731 - $1,345	60 Added 0.16%	37,908 $818,000
Q3 2023 Nov 09, 2023	BUY	$13.28 - $20.3 $7,157 - $10,941	539 Added 1.44%	37,848 $639,000
Q2 2023 Aug 08, 2023	SELL	$11.66 - $26.0 $23,156 - $51,636	-1,986 Reduced 5.05%	37,309 $511,000
Q1 2023 May 11, 2023	BUY	$19.47 - $28.49 $26,927 - $39,401	1,383 Added 3.65%	39,295 $893,000
Q4 2022 Feb 14, 2023	BUY	$18.08 - $30.0 $7,105 - $11,790	393 Added 1.05%	37,912 $892,000
Q3 2022 Nov 10, 2022	BUY	$22.51 - $34.32 $72,909 - $111,162	3,239 Added 9.45%	37,519 $978,000
Q2 2022 Aug 11, 2022	BUY	$16.0 - $45.99 $197,504 - $567,700	12,344 Added 56.27%	34,280 $752,000
Q1 2022 May 12, 2022	BUY	$33.17 - $46.98 $34,430 - $48,765	1,038 Added 4.97%	21,936 $984,000
Q4 2021 Feb 10, 2022	SELL	$39.06 - $67.58 $13,944 - $24,126	-357 Reduced 1.68%	20,898 $896,000
Q3 2021 Nov 12, 2021	BUY	$60.13 - $77.6 $50,028 - $64,563	832 Added 4.07%	21,255 $1.41 Million
Q2 2021 Aug 05, 2021	BUY	$50.07 - $76.78 $296,063 - $454,000	5,913 Added 40.75%	20,423 $1.5 Million
Q1 2021 May 06, 2021	BUY	$58.92 - $97.33 $59,332 - $98,011	1,007 Added 7.46%	14,510 $993,000
Q4 2020 Feb 10, 2021	BUY	$43.6 - $73.05 $44,777 - $75,022	1,027 Added 8.23%	13,503 $907,000
Q3 2020 Nov 12, 2020	SELL	$38.47 - $52.03 $11,079 - $14,984	-288 Reduced 2.26%	12,476 $642,000
Q2 2020 Aug 13, 2020	BUY	$27.28 - $43.01 $96,025 - $151,395	3,520 Added 38.08%	12,764 $481,000
Q1 2020 May 06, 2020	BUY	$23.08 - $35.53 $213,351 - $328,439	9,244 New	9,244 $276,000

Others Institutions Holding CSTL

# of Institutions

176

Shares Held

25.6M

Call Options Held

511K

Put Options Held

130K

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $876M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Castle Biosciences Inc Transaction History